2 March 2017 - Researchers from Auckland and Otago Universities are the first recipients of new grants from PHARMAC and the Health Research Council of New Zealand.
Professor Keith Petrie at the University of Auckland, and Dr Lianne Parkin of the University of Otago, will receive grants worth more than $210,000 each for their research.
Generic medicines are equivalent to brand name medicines, providing the same quality and performance but usually at a lower cost. Professor Petrie’s study will look at how people’s views on generic medicines can affect their acceptance of these medicines.
Metformin is the first-line treatment for type 2 diabetes, however overseas research shows that many patients don’t use it as prescribed. Dr Parkin will explore how to improve the way New Zealanders with type 2 diabetes use metformin.